E11-39. Using Statement of Cash Flow Information to Assess Company Life-Cycle Stage Consider each company's statement of cash flows as reported in assignments referenced below. Com- plete the table to (a) indicate the sign of the cash flows and (b) identify the company's life-cycle stage (introduction, growth, maturity, or decline). See Financial Cash from Information Operating in: Activities Cash from Investing Activities Cash from Financing Activities Life-Cycle Stage Company ($ millions) Amgen Inc. ................... Staples Inc. ................... Roger's Communications ........ P11-56 P11-57 111-58 P11-56. Interpreting the Statement of Cash Flows Following is the statement of cash flows of Amgen Inc. AMGEN INC. CONSOLIDATED STATEMENTS OF CASH FLOWS Years Ended December 31, 2015, 2014 and 2013 $ millions 2015 2014 2013 $ 6,939 2,108 322 (607) (399) $ 5,158 2,092 408 (108) (116) $ 5,081 1,286 403 (189) 103 (420) 136 327 (38) 481 Cash flows from operating activities: Net income............ Depreciation and amortization ....... Stock-based compensation expense .. Deferred income taxes.... Other items, net ..... Changes in operating assets and liabilities, net of acquisitions: Trade receivables, net ..... Inventories ...... Other assets ......... Accounts payable...... Accrued income taxes ........ Other liabilities ..................... Net cash provided by operating activities ........... Cash flows from investing activities: Purchases of property, plant and equipment. Cash paid for acquisitions, net of cash acquired. .... Purchases of intangible assets.. Purchases of marketable securities ...... Proceeds from sales of marketable securities ... Proceeds from maturities of marketable securities ... Proceeds from sale of property, plant and equipment.. Change in restricted investments, net ........ 155 (12) 509 228 (103) 534 8,555 (59) 60 (326) (23) 6,291 9,077 (693) (9,434) (594) (359) (55) (25,977) 18,029 3,527 274 (718) (165) (285) (25,878) 16,697 4,199 3 (21,965) 19,123 5,090 20 (520) (90) (8,469) Other.......................... (392) (5,547) 533 (138) (5,752) 3,465 (2,400) (1,867) (2,396) 4,476 (5,605) (138) (1,851) 8,054 (3,371) (832) (1,415) Net cash used in investing activities Cash flows from financing activities: Net proceeds from issuance of debt .. Repayment of debt........ Repurchases of common stock.. Dividends paid .. Net proceeds from issuance of common stock in connection with the Company's equity award programs Settlement of contingent consideration obligations.............. Other...................................... Net cash (used in) provided by financing activities ..... Increase (decrease) in cash and cash equivalents. Cash and cash equivalents at beginning of period ........ Cash and cash equivalents at end of period .......... 82 296 (253) 252 (3,117) 186 (92) 147 (2,877) (74) 3,805 $ 3,731 413 3,731 $ 4,144 2,726 548 3,257 $ 3,805 E11-39. Using Statement of Cash Flow Information to Assess Company Life-Cycle Stage Consider each company's statement of cash flows as reported in assignments referenced below. Com- plete the table to (a) indicate the sign of the cash flows and (b) identify the company's life-cycle stage (introduction, growth, maturity, or decline). See Financial Cash from Information Operating in: Activities Cash from Investing Activities Cash from Financing Activities Life-Cycle Stage Company ($ millions) Amgen Inc. ................... Staples Inc. ................... Roger's Communications ........ P11-56 P11-57 111-58 P11-56. Interpreting the Statement of Cash Flows Following is the statement of cash flows of Amgen Inc. AMGEN INC. CONSOLIDATED STATEMENTS OF CASH FLOWS Years Ended December 31, 2015, 2014 and 2013 $ millions 2015 2014 2013 $ 6,939 2,108 322 (607) (399) $ 5,158 2,092 408 (108) (116) $ 5,081 1,286 403 (189) 103 (420) 136 327 (38) 481 Cash flows from operating activities: Net income............ Depreciation and amortization ....... Stock-based compensation expense .. Deferred income taxes.... Other items, net ..... Changes in operating assets and liabilities, net of acquisitions: Trade receivables, net ..... Inventories ...... Other assets ......... Accounts payable...... Accrued income taxes ........ Other liabilities ..................... Net cash provided by operating activities ........... Cash flows from investing activities: Purchases of property, plant and equipment. Cash paid for acquisitions, net of cash acquired. .... Purchases of intangible assets.. Purchases of marketable securities ...... Proceeds from sales of marketable securities ... Proceeds from maturities of marketable securities ... Proceeds from sale of property, plant and equipment.. Change in restricted investments, net ........ 155 (12) 509 228 (103) 534 8,555 (59) 60 (326) (23) 6,291 9,077 (693) (9,434) (594) (359) (55) (25,977) 18,029 3,527 274 (718) (165) (285) (25,878) 16,697 4,199 3 (21,965) 19,123 5,090 20 (520) (90) (8,469) Other.......................... (392) (5,547) 533 (138) (5,752) 3,465 (2,400) (1,867) (2,396) 4,476 (5,605) (138) (1,851) 8,054 (3,371) (832) (1,415) Net cash used in investing activities Cash flows from financing activities: Net proceeds from issuance of debt .. Repayment of debt........ Repurchases of common stock.. Dividends paid .. Net proceeds from issuance of common stock in connection with the Company's equity award programs Settlement of contingent consideration obligations.............. Other...................................... Net cash (used in) provided by financing activities ..... Increase (decrease) in cash and cash equivalents. Cash and cash equivalents at beginning of period ........ Cash and cash equivalents at end of period .......... 82 296 (253) 252 (3,117) 186 (92) 147 (2,877) (74) 3,805 $ 3,731 413 3,731 $ 4,144 2,726 548 3,257 $ 3,805